Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
16 Oct 2024
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
ESMO 2024: Highlights and analysis
Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer
Assessment of suicide risk in cancer patients
Cancer journeys: Research from India
Depression in cancer
Managing 'fear of recurrence' of cancer patients
Psychological issues in familial cancer
Hormonal receptor positive breast cancer adjuvant and metastatic indications